RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions
Annales d'Endocrinologie · 2024-04 · 85 (2) · 118-126
DOI: 10.1016/j.ando.2024.02.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annales d'Endocrinologie, 2024-04. Verfasst von Sarah Hamidi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX, 77030, USA. Electronic address: sh…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Neuroendocrine, Multiple Endocrine Neoplasia Type 2a. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX, 77030, USA. Electronic address: shamidi@mdanderson.org.
- Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX, 77030, USA.
Förderung
- Eli Lilly and Company
Zitieren
APA
Hamidi, S., & Hu, M. I. (2024). RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions. Annales d'Endocrinologie, 85(2), 118-126. https://doi.org/10.1016/j.ando.2024.02.001
Vancouver
Hamidi S, Hu MI. RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions. Annales d'Endocrinologie. 2024;85(2):118-126. doi:10.1016/j.ando.2024.02.001
BibTeX
@article{Hamidi2024,
author = {Hamidi, Sarah and Hu, Mimi I},
title = {RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions},
journal = {Annales d'Endocrinologie},
year = {2024},
volume = {85},
number = {2},
pages = {118--126},
doi = {10.1016/j.ando.2024.02.001}
}
EUVIMED